Stock Stories
Neos Therapeutics (NEOS) to become part of Aytu BioScience (AYTU), Creating a $100 Million Revenue Specialty Pharmaceutical Co.
The pharmaceutical firm has signed a merger agreement with AytuBioScience. Aytu will purchase Neos for $44.9 million. Shares of Neos Therapeutics, Inc. (NEOS) escalated with a heavy volume on Thursday following the merger deal with AytuBioScience, Inc. (AYTU),as AYTU also soared on the partnership agreement.
